Mitochondrial bioenergetics and dynamics in Huntington's disease: Tripartite synapses and selective striatal degeneration

Journal of Bioenergetics and Biomembranes

Volumn 42, Issue 3, 2010, Pages 227-234

  Oliveira, Jorge M A ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Astrocytes; Huntington's disease; Mitochondria; Neurons; Striatum

Indexed keywords

HUNTINGTIN;

ASTROCYTE; BIOENERGY; BRAIN DEGENERATION; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CORPUS STRIATUM; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NONHUMAN; REVIEW; STRIATAL DEGENERATION; SYNAPSE; ANIMAL; ENERGY METABOLISM; METABOLISM; MITOCHONDRION; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CORPUS STRIATUM; ENERGY METABOLISM; HUNTINGTON DISEASE; MITOCHONDRIA; NERVE DEGENERATION; SYNAPSES;

EID: 77954426618     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-010-9287-6     Document Type: Review

References (58)

1. A Araque V Parpura RP Sanzgiri PG Haydon 1999 Tripartite synapses: glia, the unacknowledged partner Trends Neurosci 22 208 215 10.1016/S0166-2236(98) 01349-6 1:CAS:528:DyaK1MXivVOktbg%3D (Pubitemid 29202082)
2. L Bambrick T Kristian G Fiskum 2004 Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection Neurochem Res 29 601 608 10.1023/B:NERE.0000014830.06376.e6 1:CAS:528:DC%2BD2cXpslWisw%3D%3D (Pubitemid 38295010)
3. LL Bambrick K Chandrasekaran Z Mehrabian C Wright BK Krueger G Fiskum 2006 Cyclosporin A increases mitochondrial calcium uptake capacity in cortical astrocytes but not cerebellar granule neurons J Bioenerg Biomembr 38 43 47 10.1007/s10863-006-9004-7 1:CAS:528:DC%2BD28XmvFeitro%3D (Pubitemid 44078518)
4. E Boitier R Rea MR Duchen 1999 Mitochondria exert a negative feedback on the propagation of intracellular Ca2+ waves in rat cortical astrocytes J Cell Biol 145 795 808 10.1083/jcb.145.4.795 1:CAS:528:DyaK1MXjt1Wgsb4%3D (Pubitemid 29240856)
5. J Bradford JY Shin M Roberts CE Wang XJ Li S Li 2009 Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms Proc Natl Acad Sci U S A 106 22480 22485 10.1073/pnas.0911503106 1:CAS:528:DC%2BC3cXmsVaisA%3D%3D
6. J Bradford JY Shin M Roberts CE Wang G Sheng S Li XJ Li 2010 Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice J Biol Chem 10.1074/jbc.M109.083287
7. E Brouillet C Jacquard N Bizat D Blum 2005 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease J Neurochem 95 1521 1540 10.1111/j.1471-4159.2005.03515.x 1:CAS:528:DC%2BD28XhsVKjtQ%3D%3D (Pubitemid 41804051)
8. MR Brown PG Sullivan JW Geddes 2006 Synaptic mitochondria are more susceptible to Ca2+overload than nonsynaptic mitochondria J Biol Chem 281 11658 11668 10.1074/jbc.M510303200 1:CAS:528:DC%2BD28Xjslegur0%3D (Pubitemid 43855423)
9. SE Browne 2008 Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models Ann N Y Acad Sci 1147 358 382 1:CAS:528:DC%2BD1MXhsVaqu7Y%3D
10. N Brustovetsky T Brustovetsky KJ Purl M Capano M Crompton JM Dubinsky 2003 Increased susceptibility of striatal mitochondria to calcium-induced permeability transition J Neurosci 23 4858 4867 1:CAS:528:DC%2BD3sXltlensb8%3D
11. N Brustovetsky R LaFrance KJ Purl T Brustovetsky CD Keene WC Low JM Dubinsky 2005 Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease J Neurochem 93 1361 1370 10.1111/j.1471-4159.2005.03036.x 1:CAS:528:DC%2BD2MXlsFemsrs%3D (Pubitemid 40853259)
12. P Calabresi D Centonze G Bernardi 2000 Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum Neurology 55 1249 1255 1:CAS:528:DC%2BD3cXos12gt7c%3D
13. S Chalmers DG Nicholls 2003 The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria J Biol Chem 278 19062 19070 10.1074/jbc.M212661200 1:CAS:528:DC%2BD3sXjvVSks7o%3D (Pubitemid 36799293)
14. DT Chang IJ Reynolds 2006 Mitochondrial trafficking and morphology in healthy and injured neurons Prog Neurobiol 80 241 268 10.1016/j.pneurobio.2006. 09.003 1:CAS:528:DC%2BD2sXit12rtQ%3D%3D (Pubitemid 46028946)
15. DT Chang GL Rintoul S Pandipati IJ Reynolds 2006 Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons Neurobiol Dis 22 388 400 10.1016/j.nbd.2005.12.007 1:CAS:528: DC%2BD28XktVyjs7o%3D
16. H Chen DC Chan 2009 Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases Hum Mol Genet 18 R169 R176 10.1093/hmg/ddp326 1:CAS:528:DC%2BD1MXhtlCqu7nN
17. YS Choo GV Johnson M MacDonald PJ Detloff M Lesort 2004 Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release Hum Mol Genet 13 1407 1420 10.1093/hmg/ddh162 1:CAS:528:DC%2BD2cXlt1WlsL4%3D (Pubitemid 39023049)
18. DM Chuang Y Leng Z Marinova HJ Kim CT Chiu 2009 Multiple roles of HDAC inhibition in neurodegenerative conditions Trends Neurosci 32 591 601 10.1016/j.tins.2009.06.002 1:CAS:528:DC%2BD1MXhtlWisLnN
19. GA Dienel L Hertz 2005 Astrocytic contributions to bioenergetics of cerebral ischemia Glia 50 362 388 10.1002/glia.20157 (Pubitemid 40780841)
20. L Djousse B Knowlton LA Cupples K Marder I Shoulson RH Myers 2002 Weight loss in early stage of Huntington's disease Neurology 59 1325 1330 1:STN:280:DC%2BD38nmslKmsw%3D%3D
21. A Domingues S Almeida EF da Cruz e Silva CR Oliveira AC Rego 2007 Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits Neurochem Int 50 872 880 10.1016/j.neuint.2007.03.001 1:CAS:528:DC%2BD2sXltF2ls7s%3D (Pubitemid 46710199)
22. S Gines E Ivanova IS Seong CA Saura ME MacDonald 2003 Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells J Biol Chem 278 50514 50522 10.1074/jbc.M309348200 1:CAS:528:DC%2BD3sXpslSqtLc%3D (Pubitemid 37548897)
23. HH Goebel R Heipertz W Scholz K Iqbal I Tellez-Nagel 1978 Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies Neurology 28 23 31 1:CAS:528:DyaE1cXhtVaqt7Y%3D
24. M Gu MT Gash VM Mann F Javoy-Agid JM Cooper AH Schapira 1996 Mitochondrial defect in Huntington's disease caudate nucleus Ann Neurol 39 385 389 10.1002/ana.410390317 1:CAS:528:DyaK28XisFyrsbo%3D (Pubitemid 26100764)
25. JF Gusella ME MacDonald 2000 Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease Nat Rev Neurosci 1 109 115 10.1038/35039051 1:CAS:528:DC%2BD3MXivVSitLo%3D
26. HY Hsiao Y Chern 2010 Targeting glial cells to elucidate the pathogenesis of Huntington's disease Mol Neurobiol 10.1007/s12035-009-8097-5
27. H Ilieva M Polymenidou DW Cleveland 2009 Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond J Cell Biol 187 761 772 10.1083/jcb.200908164 1:CAS:528:DC%2BD1MXhsF2qtb3F
28. MB Jekabsons DG Nicholls 2004 In situ respiration and bioenergetic status of mitochondria in primary cerebellar granule neuronal cultures exposed continuously to glutamate J Biol Chem 279 32989 33000 10.1074/jbc.M401540200 1:CAS:528:DC%2BD2cXmtVChu7g%3D (Pubitemid 39014759)
29. O Kann R Kovacs 2007 Mitochondria and neuronal activity Am J Physiol Cell Physiol 292 C641 C657 10.1152/ajpcell.00222.2006 1:CAS:528:DC%2BD2sXjt1Gmtb4%3D
30. AG Kazantsev LM Thompson 2008 Therapeutic application of histone deacetylase inhibitors for central nervous system disorders Nat Rev Drug Discov 7 854 868 10.1038/nrd2681 1:CAS:528:DC%2BD1cXhtFOlu7rK
31. PC Klohn ME Soriano W Irwin D Penzo L Scorrano A Bitsch HG Neumann P Bernardi 2003 Early resistance to cell death and to onset of the mitochondrial permeability transition during hepatocarcinogenesis with 2-acetylaminofluorene Proc Natl Acad Sci U S A 100 10014 10019 10.1073/pnas.1633614100 (Pubitemid 37087060)
32. L Leventhal CE Sortwell R Hanbury TJ Collier JH Kordower S Palfi 2000 Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity J Comp Neurol 425 471 478 10.1002/1096- 9861(20001002)425:4<471::AID-CNE1>3.0.CO;2-U 1:CAS:528: DC%2BD3cXmvVWms7o%3D
33. JC Lievens S Birman 2007 Astrocytes in Huntington's chorea: accomplice or guilty of the neuronal death? Med Sci (Paris) 23 845 849
34. MT Lin MF Beal 2006 Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 787 795 10.1038/nature05292 1:CAS:528:DC%2BD28XhtVyktbbO (Pubitemid 44622683)
35. G Liot B Bossy S Lubitz Y Kushnareva N Sejbuk E Bossy-Wetzel 2009 Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway Cell Death Differ 16 899 909 10.1038/cdd.2009.22 1:CAS:528:DC%2BD1MXlvV2gtLo%3D
36. CS Lobsiger DW Cleveland 2007 Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease Nat Neurosci 10 1355 1360 10.1038/nn1988 1:CAS:528:DC%2BD2sXht1ajsbfF (Pubitemid 350014678)
37. B Monti E Polazzi A Contestabile 2009 Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection Curr Mol Pharmacol 2 95 109 10.2174/1874467210902010095 1:CAS:528:DC%2BD1MXkvVSgt70%3D
38. Oliveira JM (2010a) Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on Huntingtin and the Striatum. J Neurochem doi: 10.1111/j.1471-4159.2010.06741.x
39. Oliveira JM (2010b) Techniques to investigate neuronal mitochondrial function and its pharmacological modulation. Curr Drug Targets. Accepted for publication
40. JM Oliveira J Gonçalves 2009 In situ mitochondrial Ca2+ buffering differences of intact neurons and astrocytes from cortex and striatum J Biol Chem 284 5010 5020 10.1074/jbc.M807459200 1:CAS:528:DC%2BD1MXhvVSns7c%3D
41. JM Oliveira J Gonçalves 2009 Neuronal and astrocytic mitochondrial dynamics as vulnerability factors and targets for neuroprotection [Abstract] Frontiers Neurosci 10.3389/conf.neuro.01.2009.11.041
42. JM Oliveira S Almeida A Domingues LM Ellerby J Gonçalves CR Oliveira AC Rego 2004 Calcium mobilising pathways and Δψm in striatal progenitor cells [Abstract] Fund Clin Pharmacol 18 suppl. 1 P19.36 10.1111/j.1472-8206.2004.00260.x
43. JM Oliveira S Chen S Almeida R Riley J Gonçalves CR Oliveira MR Hayden DG Nicholls LM Ellerby AC Rego 2006 Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors J Neurosci 26 11174 11186 10.1523/JNEUROSCI.3004-06.2006 1:CAS:528:DC%2BD28XhtFymsLbN (Pubitemid 44772205)
44. JM Oliveira MB Jekabsons S Chen A Lin AC Rego J Gonçalves LM Ellerby DG Nicholls 2007 Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice J Neurochem 101 241 249 10.1111/j.1471-4159.2006.04361.x 1:CAS:528: DC%2BD2sXksFSqtro%3D (Pubitemid 46426480)
45. AL Orr S Li CE Wang H Li J Wang J Rong X Xu PG Mastroberardino JT Greenamyre XJ Li 2008 N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking J Neurosci 28 2783 2792 10.1523/JNEUROSCI.0106-08.2008 1:CAS:528:DC%2BD1cXjvVagurs%3D (Pubitemid 351398886)
46. AV Panov CA Gutekunst BR Leavitt MR Hayden JR Burke WJ Strittmatter JT Greenamyre 2002 Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines Nat Neurosci 5 731 736 1:CAS:528: DC%2BD38XlsFaqu7g%3D
47. G Perea M Navarrete A Araque 2009 Tripartite synapses: astrocytes process and control synaptic information Trends Neurosci 32 421 431 10.1016/j.tins.2009.05.001 1:CAS:528:DC%2BD1MXps1aju7Y%3D
48. RC Reyes V Parpura 2008 Mitochondria modulate Ca2+-dependent glutamate release from rat cortical astrocytes J Neurosci 28 9682 9691 10.1523/JNEUROSCI.3484-08.2008 1:CAS:528:DC%2BD1cXht1SnsrnP
49. IJ Reynolds LM Malaiyandi M Coash GL Rintoul 2004 Mitochondrial trafficking in neurons: a key variable in neurodegeneration? J Bioenerg Biomembr 36 283 286 10.1023/B:JOBB.0000041754.78313.c2 1:CAS:528:DC%2BD2cXnsFyis7Y%3D (Pubitemid 39619827)
50. GL Rintoul AJ Filiano JB Brocard GJ Kress IJ Reynolds 2003 Glutamate decreases mitochondrial size and movement in primary forebrain neurons J Neurosci 23 7881 7888 1:CAS:528:DC%2BD3sXmvFGhurg%3D
51. DJ Rossi JD Brady C Mohr 2007 Astrocyte metabolism and signaling during brain ischemia Nat Neurosci 10 1377 1386 10.1038/nn2004 1:CAS:528: DC%2BD2sXht1ajsbnE (Pubitemid 350014689)
52. JY Shin ZH Fang ZX Yu CE Wang SH Li XJ Li 2005 Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity J Cell Biol 171 1001 1012 10.1083/jcb.200508072 1:CAS:528:DC%2BD2MXhtlequ7fF (Pubitemid 41815832)
53. F Squitieri L Frati A Ciarmiello S Lastoria O Quarrell 2006 Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease? Mech Ageing Dev 127 208 212 10.1016/j.mad.2005.09.012 (Pubitemid 43165620)
54. AJ Tobin ER Signer 2000 Huntington's disease: the challenge for cell biologists Trends Cell Biol 10 531 536 10.1016/S0962-8924(00)01853-5 1:CAS:528:DC%2BD3cXot12ltLo%3D
55. E Trushina, et al. 2004 Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro Mol Cell Biol 24 8195 8209 10.1128/MCB.24.18.8195-8209.2004 1:CAS:528:DC%2BD2cXnslCrsbY%3D (Pubitemid 39167467)
56. G Twig B Hyde OS Shirihai 2008 Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view Biochim Biophys Acta 1777 1092 1097 10.1016/j.bbabio.2008.05.001 1:CAS:528:DC%2BD1cXpvF2qt7g%3D
57. H Wang PJ Lim M Karbowski MJ Monteiro 2009 Effects of overexpression of huntingtin proteins on mitochondrial integrity Hum Mol Genet 18 737 752 10.1093/hmg/ddn404 1:CAS:528:DC%2BD1MXhtVWjsbs%3D
58. X Wang B Su L Zheng G Perry MA Smith X Zhu 2009 The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease J Neurochem 109 Suppl 1 153 159 10.1111/j.1471-4159.2009.05867.x 1:CAS:528: DC%2BD1MXlsFyksbk%3D